March 24, 2010 – A team of Mayo Clinic researchers found that cardiac rehabilitation is associated with significantly reduced mortality rates for patients who receive coronary stents. The findings were presented last week at the annual meeting of the American College of Cardiology in Atlanta.

March 23, 2010 – Frost and Sullivan gave a 2010 North American New Product Innovation Award to Positron Corp. for its pioneering cardiac positron emission tomography (PET) scanner, the Attrius.

March 23, 2010 – The U.S. Food and Drug Administration (FDA) recently added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and healthcare professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form.

March 18, 2010 — A cardiac cryoablation catheter system designed for patients with paroxysmal atrial fibrillation (PAF) has completed premarket approval and is under review by the U.S. Food and Drug Administration (FDA).

March 23, 2010 – At ACC last week Medtronic launched the Every Patient First health equity initiative, in partnership with healthcare providers, and professional societies, to reduce disparities in access to healthcare in the United States.

March 22, 2010 – A pivotal clinical trial recently began to gain U.S. approval for a defibrillator system that does not have any leads in or on the heart. Additionally, no imaging equipment is required for placement of the system, since all of the components are positioned using anatomical landmarks.